These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 7862839

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of KATP channels in reduced antinociceptive effect of morphine in streptozotocin-induced diabetic mice.
    Sood V, Sharma A, Singh M.
    Indian J Exp Biol; 2000 May; 38(5):447-51. PubMed ID: 11272407
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
    Drower EJ, Stapelfeld A, Rafferty MF, de Costa BR, Rice KC, Hammond DL.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C, Saitoh A, Tamura N, Kamei J.
    Eur J Pharmacol; 2005 Nov 07; 524(1-3):75-9. PubMed ID: 16256106
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
    Qi JN, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1990 Aug 07; 254(2):683-9. PubMed ID: 2166801
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception.
    Lohmann AB, Welch SP.
    Eur J Pharmacol; 1999 Nov 19; 384(2-3):147-52. PubMed ID: 10611434
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J, Kawashima N, Hitosugi H, Misawa M, Nagase H, Kasuya Y.
    Brain Res; 1993 Aug 13; 619(1-2):76-80. PubMed ID: 8374794
    [Abstract] [Full Text] [Related]

  • 37. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.
    Ocaña M, Baeyens JM.
    Br J Pharmacol; 1993 Nov 13; 110(3):1049-54. PubMed ID: 7905339
    [Abstract] [Full Text] [Related]

  • 38. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
    Suzuki T, Tsuji M, Mori T, Misawa M, Endoh T, Nagase H.
    Life Sci; 1995 Nov 13; 57(2):155-68. PubMed ID: 7603296
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice.
    Murray CW, Cowan A.
    Psychopharmacology (Berl); 1990 Nov 13; 102(3):425-6. PubMed ID: 2251341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.